Subcutaneous implantable cardioverter-defibrillators (S-ICD) provide an alternative to traditional transvenous implantable cardioverter-defibrillators (TV-ICD) and avoid complications associated with intravascular access and leads. They are highly effective in detecting and treating ventricular arrhythmias, with comparable inappropriate shock rates.1 Use of S-ICD is anticipated to increase significantly.2
No takes yet. Share an insight, caveat, or question.
Sugumar et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: